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Abstract
Caudal epidural injections are one of the commonly used interventions in managing chronic low back pain.
The caudal approach to epidural space was first reported by Sicard in 1901. Injection of steroids to treat low
back pain was introduced in 1952.
Corticosteroids delivered into epidural space demonstrate higher local concentrations over an inflamed nerve
root and will be more effective than a steroid administered either orally or by intramuscular injection. The
clinical effectiveness evaluations fill the literature with various types of reports including randomised clinical
trials, prospective trials, retrospective studies, case reports, and meta-analyses. Evidence from all types of
evaluations with regard to clinical outcomes and cost-effectiveness of caudal epidural injections is encourag-
ing. Reports of the effectiveness of all types of epidural steroids vary from 18% to 90%. One of the reasons for
this discrepancy is the difficulty in accurate identification of caudal epidural space and inaccurate needle
placement when performed without imaging guidance in a substantial number of patients. Caudal epidural
injection is a safe, effective technique when performed with due care. In many centres this procedure is
performed under fluoroscopic or ultrasound guidance.
In our study we used stimulation with a radiofreqency needle to identify caudal epidural space for low back
pain treatment (30 patients).
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Introduction
Sacral access to epidural space is one of the old-
est techniques applied for the purpose of perform-
ing blocks or the injection of steroids. Sacrally ad-
ministered epidural anaesthesia was described for
the first time by Sicarda in 1901, who was the first
to apply local anaesthesia via this route [1]. This
technique is at present widely used to administer
anaesthesia in paediatric units. Finding epidural
space for sacral access in children is technically
easier [2]. In adults, this access to epidural space is
seldom used for the purpose of anaesthesia before
surgical procedures owing to frequent difficulties
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rooted in anatomic variety, which cause technical
difficulties in obtaining such access [3].
Sacral access to epidural space in adults gained
popularity in 1952, when corticosteroids were add-
ed to local anaesthetics. At present, this technique
is commonly used for the purpose of supplying ste-
roids in the treatment of acute and chronic pain.
Disk herniation, spinal stenosis or spondylolystesis
accompanied by spinal stenosis constitute the most
frequent reasons for lower back pain and the ac-
companying radicular symptoms. Epidural applica-
tion of steroids is one of the more frequently used
methods of treatment in exacerbations of pain symp-
toms in lumbar spine that radiate to limbs, in radic-
ular pain and in pain syndromes following ineffec-
tive spinal surgery [4, 5].
Epidural sacral access can also be applied to the
diagnostic stimulation of sacral nerves in interstitial
cystitis.
When performing this procedure in our centre in
three patients with interstitial cystitis using a ther-
molesion needle and an RF generator, distinct reac-
tions were observed to motor stimulation at the
frequency of 2 Hz and sensory stimulation at the
frequency of 50–100 Hz [6]. This induced us to at-
tempt to identify sacral epidural space using a ther-
molesion needle and an RF generator before the
therapeutic delivery of steroids.
The focus of the present paper is to present a
new method for the identification of sacral epidural
space in using a thermolesion needle.
Anatomical and technical issues
When choosing sacral access to epidural space,
one ought to consider certain anatomical matters
and also a host of other factors that may cause
technical problems in the correct identification of
sacral epidural space, and thereby prevent the de-
livery of the medication in the intended location.
The sacral bone is a triangular bone. It is a tilted-
back structure containing five fused sacral verte-
brae. The sacral bone articulates with four bones:
the last lumbar vertebra above, the coccyx (tailbone)
below and the illiac portion of the hip bone on
either side. The sacral bone contains two sets of
four pairs of openings: four pairs of anterior and
four pairs of posterior sacral openings. The front
sacral openings make it possible for the local anaes-
thetic to seep from the sacral canal and epidural
space, which does not apply to the posterior open-
ings, which are covered by adjoining muscles. The
base of the coccyx is connected with the sacral bone
via the sacrococcygeal joint. The sacrococcygeal lig-
ament covers the median sacral hiatus and is limi-
ted laterally by the sacral horns. The sacral hiatus
remains open in the lower part of the back wall,
formed from the S5 lamella and usually partly S4
(that also form an incomplete arch), unite in the
median part [7].
The sacral epidural space is shapes like an invert-
ed “U” and is covered by dorsal fibres of the sacro-
coccygeal ligament.
The sacral canal contains, apart from sacral and
caudal nerves as well as the terminal filum (filium
terminals), also epidural venous plexuses reaching
the level of S4, located in the anterior part of the
sacral canal. Besides, there is a certain amount of
epidural fat. The terminal portion of the meningeal
sac is relative to the age: in adults, it reaches S1, but
in children in can reach up to S3. Certain anatomical
details also vary by sex, race and age, should always
be considered when deciding on the administration
of medicines via the sacral epidural access. In pa-
tients with normal anatomy, needle insertion into
the sacral epidural space is usually easy and safe.
However, there are a number of reasons that make it
difficult to insert the needle through the sacral hia-
tus. The injected solution may not reach the sacral
canal, the needle may miss the sacral openings with
the medicine not being delivered to the intended
location. There are a number of reasons for failure to
administer medicines epidurally, among others
changes in the curvature of the sacral bone (the bone
may be bent centrally or in its lower one-third), limit-
ing the possibility of an accurate needle insertion,
obesity which makes it difficult to locate the sacral
horns by palpation, and consequently, the sacral hia-
tus, occurs in 5–10% patients. Attempts to perform
the injection in an unguided manner usually result in
technical difficulties and are unpleasant and trau-
matic for the patient. Such attempts often end in
failure. Insufficient experience is one of the other
reasons for failure in the epidural administration of
medicines. Pre-existing concomitant arachnoiditis,
both in its clinical and subclinical forms, can be the
reason behind a protracted block after sacral epidur-
al steroid administration (lengthened uptake and
binding of medicine by 5–6). If the needle impinges
on the body of the sacral bone, intraosseal applica-
tion may occur [7, 8].
Potential reasons for the difficulty in access to
sacral epidural space include: short height, short
saggital dimension of the sacral bone, unguided
injection, inexperienced physician performing the
procedure, the end of the needle reaching above
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S1, non-atypical anatomy, acute angle of the sacral
bend, impossibility to identify individual anatomi-
cal structures (obesity), deformation of the sacral
region or an excessively long coccyx [8].
In order to improve the effectiveness and ease
of identification of epidural space, the use of imag-
ing techniques is suggested, such as fluoroscopy or
ultrasound, which permit an accurate location of
the target site of application of medicines [9, 10].
A technique for the identification
of epidural space by means
of a thermolesion needle
and an RF generator
In our study, for the purpose of identifying sac-
ral epidural space we used the equipment available
at our centre: Radiofrequency Lesion Generator Sys-
tem, Radinics Model RFG-3C. All epidural procedures
were performed based on indications in outpatients
of our Pain Treatment Centre after they expressed
written informed consent.
The patient was placed on the side, with legs
flexed at hips and knees and the head bent close to
the trunk (foetal position). Then the sacral area was
prepped with antiseptic solution (indispensable pro-
cedure due to the proximity of the anus). Sacral
horns were palpated and then the sacral hiatus.
After identifying the place of insertion and the sub-
cutaneous tissue overlying the sacral hiatus was in-
filtrated with 1% lidocaine using a 5-ml syringe and
25-Gx 1,5 gauge needle. During the procedure, the
administration of steroids guided by thermolesion
equipment was performed using the Top Neuro-
pole Needle XE 23G, length 60 mm, active tip length
5 mm. After initial anaesthesia at the place of inser-
tion, the needle was inserted through the sacral
hiatus at the 45° angle, but after insertion into the
sacral hiatus, the angle was reduced so that the
needle was placed almost horizontally. Subsequent-
ly, the needle was shifted cephalad so that the tip
of the needle impinged on the dorsal part of the
vertebral canal. The needle was then withdrawn
gently approx. 2–3 mm. Then it was aspirated for
blood or cerebrospinal fluid using a 10 ml syringe.
In order to confirm proper needle placement, two
kinds of stimulation were performed using our ther-
molesion equipment: motor stimulation at 50 Hz
and sensory stimulation at 2 Hz. During motor stim-
ulation, was observed the contraction of muscles
supplied by the stimulated nerves. During sensory
stimulation, the patient feels tingling or an sense of
expansion in the region affected by the stimulation.
Once the sensory and motor stimulation results have
confirmed correct needle placement in the sacral
epidural space, the patients received a mixture of a
depot steroid. Most clinicians usually apply 14 mg
of betamethasone in saline solution, volume 5–25
ml [11–13].
During the procedure, the following parameters
are monitored: cardiac rhythm (cardiomonitor),
pulseoxymetry and arterial blood pressure.
After the procedure, patients are transferred to
the observation room, where they remain under the
care of a qualified surgical nurse for 40–60 min,
and before leaving the Centre, are seen by the phy-
sician who has performed the procedure.
Material
The decision to administer steroids epidurally
was taken if the patient complained about moder-
ate to strong pain, while previous treatment was
not effective [11–13]. Before the execution of the
procedure, they were interviewed for demographic
data, information concerning pain complaints —
time of onset, type, location, radiating or not, dura-
tion, aggravating factors and pain-reducing factors.
Questions were also asked concerning previous treat-
ment both of the presenting complaint and any
other concomitant conditions, previous procedures,
hospitalisations, medicines applied, including anal-
gesics (type, dosage, duration of administration).
Also assessed was the impact of pain on patient’s
functional capacity. Clinical assessment, including
radiological imaging, was also performed. Pain in-
tensity was evaluated using a numerical rating scale
(NRS). Pain evaluation was conducted during stan-
dard activities (standing, walking) and at rest.
The identification of sacral epidural space using
the needle and the radiofrequency equipment was
carried out in 30 adult patients treated at the Pain
Treatment Centre in 2009. Patients were qualified
to epidural steroid administration because of per-
sistent pain complaints of the lower back caused by
a pathology of the intervertebral disk with concom-
itant radicular pain, stenosis of the vertebral canal,
a failed back surgery syndrome (post-ineffective spi-
nal surgery pain syndrome) and coccygodynia. Af-
ter the above-described identification of epidural
space, these patients were administered the steroid
to epidural space.
Effects of the procedure performed were evalu-
ated on day 7 and 30 after the epidural administra-
tion of steroids after the identification of sacral epi-
dural space using the needle and radiofrequency
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(thermolesion) equipment. At selected points of
time, patients were asked about the mean pain in-
tensity measured on a Numerical Scale (NRS), treat-
ment satisfaction rate using a five-point Treatment
Satisfaction Scale (1 — complete improvement, 2
— slight improvement, 3 — no change, 4 — slight
deterioration, 5 — complete deterioration) and func-
tional improvement expressed as percentage points.
Middle age of the patients 45, 56 years (33–
70).Complaints and the number of patients under-
going the procedures are shown in Table 1.
Results
The study of the effectiveness of the stimulation
by means of the needle and thermolesion equip-
ment as methods of identification of sacral epidural
space was carried out on a group of 30 patients. In
all cases, this method was applied before the
planned administration of steroids to sacral epidur-
al space. The mean duration of the complaint was
255.1 days (7–1825 days). Mean pain intensity mea-
sured on the numerical rating scale during the pre-
procedural patient evaluation was 8.2 during activ-
ity (6–10), and 3.86 at rest (0–6). NRS at one week
after treatment was 2.16 (0–6) and at one month
2.89 (0–6).
The improvement of overall functional capacity
was evaluated in percentage points. At one week
after treatment, the mean improvement rate was
53.33% (0–85%) and at one month 54.8% (0–90%).
Treatment satisfaction was measured on a five-
point scale at one week (mean value 1.93) and at
one month (with similar results). It follows that most
patients reported complete or significant relief in
pain complaints, which additionally confirms that
epidural space was correctly located with the ste-
roids deposited in the right location. The results
obtained are shown in Table 2.
Discussion
There are a number of access options to epidur-
al space in the lumbosacral spine, however sacral
access is usually used for the purpose of injecting
local anaesthetics or steroids [7, 9]. Bogduk et al.
and Manchikanti et al. compared the efficacy of
steroid injection into epidural space via the transfo-
raminal and the intralaminar routes with the sacral
epidural route. In their research, they demonstrated
the superiority of spinal access over intralaminar
access and comparable with transforaminal access.
Intralaminar access permits the administration of
medicines close to places with an identifiable pa-
thology, whereas transforaminal access permits the
use of relatively small volumes to act locally, where
pain experiences arise. Epidural sacral access is con-
sidered to be the safest and easiest, while at the
same time the carrying the least risk of inadvertent
dural puncture. The evidence quoted above also
proved the superiority of this method over the in-
tralaminar access [13, 14].
In the case of corticosteroid injections into sac-
ral epidural space after accurate identification of
the target location (sacral hiatus), the needle is in-
setred into epidural space in the sacral canal. Many
authors suggest the necessity of the exercise of this
procedure under fluoroscopic control. A number of
publications indicate that the performance of an
unguided injection, i.e. without fluoroscopic con-
trol, causes incorrect needle positioning (i.e. out-
side epidural space, intravascular, at a different lev-
el from planned access site) in ca. 30–40% of cases
. Sacral epidural application of medicines undertak-
en under fluoroscopic control is acknowledged to
constitute the golden standard that improves the
efficacy of this procedure owing to the opportunity
to accurately locate the needle in epidural space, as
long as there are no contraindications to the use of
fluoroscopy [15].
Other possibilities facilitating the identification
of sacral bone horns, and consequently, the sacral
hiatus and accurate needle placement in epidural
space include ultrasound techniques. This technolo-
gy is used especially for sacral epidural anaesthesia
in children [2].
The identification of epidural space can be aided
by the so-called “whoosh test”, which consists in
Table 1. The type of pain and the number of patients evaluated, sex
Diagnosis Number of patients (N) Sex (male/female)
Discogenic pain, radicular (ds.) 20 11/9
Spinal stenosis (St.) 2 1/1
Coccygodynia (Cc.) 3 0/3
Failed back surgery syndrome. Pain syndromes
after ineffective operations involving the spine (Fbss.) 5 2/3
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stethoscopic auscultation of the sacral bone area
during the administration of air to epidural space
after its identification [16, 17]. The modification of
this test for children is the “swoosh test,” in which
saline is administered instead of air to epidural space
[18].
Additionally, correct needle placement in epidu-
ral space can be verified by the sense of expansion
pressure or compression felt by the patient when
the solution is injected into epidural space.
The mechanism mediating the effects of epidur-
ally administered local anaesthetics and steroids is
not yet well understood. It is thought that medi-
cines cause a nerve fibre block, causing inhibition of
conductance in afferent fibres, also inhibit self-in-
duced neurone stimulations in the central nervous
system. Corticosteroids inhibit the inflammatory re-
sponse by inhibiting the synthesis or release of in-
flammatory mediators and also by the reversible
local anaesthetic effect [19, 20]. The action of gly-
cocorticosteroids in epidural space is explained by
their strong anti-inflammatory effects. Lower back
pain is often related to a coexisting inflammatory
process. The coexistence of the inflammatory pro-
cess with radicular pain was demonstrated in 1981.
Ryan and Taylor, while examining the cerebrospinal
fluid drawn during subarachnoid and epidural in-
jections, observed that the inflammatory response
constituted the most important factor in radicular
pain. They also noted a markedly better response to
intraspinal steroids during the acute phase of the
complaint, i.e. before the fibrination of the nervous
roots or axon degeneration occurs [21].
Advantages that accrue from the use of steroids,
especially pain relief that lasts for hours, days or
even weeks, are related to the pharmacological in-
fluence of medicines used.
A number of studies have demonstrated the ef-
ficacy of sacral epidural steroids in patients with
lower back pain and radicular pain (EBM for short-
lasting level I relief, moderate EBM for long-lasting
relief). There are no well documented studied on
the use of steroids in patients with the failed back
surgery syndrome (pain syndrome after ineffective
operations involving the spine) and spinal stenosis
[22, 23].
One prospective randomised double-blind study
which compared the efficacy of epidural steroid
administration under fluoroscopic control with lo-
cal steroid placement aided by an endoscope placed
in epidural space in patients with radicular pain. In
patients who received steroids under fluoroscopic
control, pain relief was maintained for up to six
months. There was no noticeable difference in the
pain sensation in the group of patients who re-
ceived the steroid under endoscopic control [24].
In a number of publications over the years con-
cerning the efficacy of epidural steroids regardless
of the manner of their administration, the efficacy
is estimated at 18–90%. One of the reasons of such
variance are difficulties with the proper identifica-
tion of epidural space and the impossibility to place
needle accurately if the procedure is performed with-
out guidance [12, 13, 25].
Incorrect needle location during sacral epidural
steroid administration occurs 25–38.5% of patients
when performed without fluoroscopic control [25–
27]. It may occur even if the sacral hiatus is well
palpated and is described in 12.5% to 14.2% of
cases (needle located outside epidural space or in-
travascularly) [19, 21, 26]. White demonstrated in-
accurate needle placement during epidural admin-
istration of steroids in nearly 25% of patients in
whom the procedure was performed by experienced
anaesthetists and orthopaedists [5].
Manchikanti documented incorrect needle place-
ment in 20% of patients, of which intravascular nee-
dle placement was observed in 7%, whereas needle
placement outside epidural space was observed in
13% [25]. Renfrew evaluated epidural steroid ad-
ministration by radiologists and documented inac-
curate needle placement in 38% of patients [9].
Preliminary results of our observations of 30 pa-
tients with lower back pain who received epidural
steroids with epidural space being identified by
means of the needle and thermolesion equipment
have shown the efficacy of this method and pain
relief by > 50% in 70% of patients.
In our study, we have demonstrated the efficacy
of epidural steroid administration at seven days from
injection, which additionally confirms correct nee-
dle placement in epidural space, aside from for the
clearly felt motor and sensory stimulation using ther-
molesion equipment to identify epidural space.
Correct needle-tip placement was additionally
confirmed by the sense of expansion pressure or
compression during the injection of several millili-
tres of saline solution into epidural space before
glycocorticosteroid administration. This symptom
was described by many authors, however, it cannot
be treated as the only test confirming the correct
needle-tip placement in epidural space [17, 18, 28].
An even clearer proof of correct needle place-
ment by means of electric sensory and motor stim-
ulation was offered by comparative studies in which,
after obtaining the desired response to electric stim-
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ulation, imaging control of needle placement was
also performed. Further comparative research using
both methods is planned in our centre.
A defect of the proposed identification technique
is the relatively high cost of the needle indispens-
able for the execution of the procedure and the
need for thermolesion equipment. However, in cen-
tres that already have such equipment, this proce-
dure may be performed without exposing the pa-
tient and the staff to RTG radiation.
The identification of epidural space using the
needle and radiofrequency (thermolesion) equip-
ment can improve the efficacy of epidural steroid
administration in patients in whom this treatment
method can offer a good therapeutic effect. Results
of our preliminary studies inspired us to further re-
search. The stimulation by means of the needle and
thermolesion equipment is an easy and safe meth-
od and can improve treatment efficiency. In order
to confirm our initial observations, further studies
are necessary involving a larger group of patients.
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